Table 1.
Variable | ABCB1 analysis group | TLDA analysis group | ||
---|---|---|---|---|
N = 93 | N = 16 | |||
NPT | PCa | NPT | PCa | |
N = 15 + 10a | N = 78 | N = 6 | N = 10 | |
Mean age in years ± SEM | 62.13 ± 1.01 | 60.76 ± 0.85 | 61.33 ± 1.09 | 62.9 ± 2.04 |
Pathological stage | ||||
pT2 | 52 | 5 | ||
pT3 | 25 | 5 | ||
Gleason score | ||||
6 | 18 | 3 | ||
≥ 7 | 54 | 7 | ||
Unknown | 1 | |||
BCR | ||||
Yes | 20 | 5 | ||
No | 53 | 5 | ||
Unknown | 5 | |||
TMPRSS2-ERG status | ||||
Positive | 51 | 6 | ||
Negative | 27 | 4 | ||
Mean PSA level at diagnosis, ng/ml ± SEM | 10.57 ± 1.25 | 11.07 ± 3.03 | ||
Methylation status of ABCB1 promoter | ||||
Methylated | 4 | 56 | 5 | |
Unmethylated | 15 | 22 | 5 | |
Unknown | 6 | 6 | ||
Mean expression of ABCB1, ∆Cq ± SEM | 7.50 ± 0.24 | 8.14 ± 0.13 | 5.01 ± 0.18 | 5.61 ± 0.17 |
aTen additional samples were included in ABCB1 methylation analysis